Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

EBPL antibody (AA 177-206)

The Rabbit Polyclonal anti-EBPL antibody has been validated for FACS, WB, IHC and ELISA. It is suitable to detect EBPL in samples from Human.
Catalog No. ABIN2599422

Quick Overview for EBPL antibody (AA 177-206) (ABIN2599422)

Target

See all EBPL Antibodies
EBPL (Emopamil Binding Protein-Like (EBPL))

Reactivity

Human

Host

  • 8
Rabbit

Clonality

  • 8
Polyclonal

Conjugate

  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
This EBPL antibody is un-conjugated

Application

  • 8
  • 8
  • 7
  • 6
  • 2
Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (IHC), ELISA
  • Binding Specificity

    • 7
    • 2
    • 1
    AA 177-206

    Specificity

    This EBPL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 177-206 amino acids from the C-terminal region of human EBPL.

    Purification

    Affinity purified

    Isotype

    IgG
  • Application Notes

    Approved: ELISA (1:1000), Flo (1:10 - 1:50), IHC (1:50 - 1:100), WB (1:100 - 1:500)

    Comment

    Target Species of Antibody: Human

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    Lot specific

    Buffer

    PBS,  pH 7.2, 0.09 % sodium azide.

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Aliquot to avoid repeated freezing and thawing.

    Storage

    4 °C,-20 °C

    Storage Comment

    May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
  • Target

    EBPL (Emopamil Binding Protein-Like (EBPL))

    Alternative Name

    EBPL

    Background

    Name/Gene ID: EBPL

    Synonyms: EBPL, ERP, Emopamil-binding protein-like, RP11-432M24.2, EBRP, Emopamil binding protein-like

    Gene ID

    84650
You are here:
Chat with us!